PubMed Health⌕ Search

Biomedical subjects

M A Denke

Publications and source records attributed to M A Denke.

At least 37 records · Page 2Linked to original sources

Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hypercholesterolemia.

Plant sterols have been shown to reduce dietary cholesterol absorption and hence, total and low-density-lipoprotein (LDL)-cholesterol concentrations in humans. In this study the cholesterol-lowering effects of dietary supplementation with the hydrogenated plant sterol sitostanol (3 g/d) were tested in 33 men with moderate hypercholesterolemia who were consuming an outpatient diet in which dietary cholesterol was restricted to < 200 mg/d. Sitostanol therapy did not significantly lower LDL cholesterol compared with the diet alone. Similarly, sitostanol therapy in conjunction with a cholesterol-lowering regimen of diet and 8 g cholestyramine did not significantly lower LDL-cholesterol concentrations. Hence, although previous reports have suggested that low-dose sitostanol therapy is an effective means of reducing LDL-cholesterol concentrations, its effectiveness may be attenuated when the diet is low in cholesterol.

Adult↗

Review of human studies evaluating individual dietary responsiveness in patients with hypercholesterolemia.

Individual variation in the low-density-lipoprotein (LDL)-cholesterol response to a cholesterol-lowering diet has been well documented in inpatient and outpatient diet studies. This variation could be due to both clinical and biological factors. Clinical factors include adherence to dietary changes and changes in body weight. Biological factors include specific changes in dietary composition, initial serum cholesterol concentrations, presence of excess body weight, the fractional catabolic rate of LDL with a diet high in saturated fatty acid, the presence of specific isoforms of apoprotein E and apoprotein A-IV, changes in the gene encoding apoprotein B or the apoprotein A-I promoter region, and the ultracentrifugation pattern of LDL lipoproteins. Work exploring the metabolic basis for individual variation in responsiveness to a cholesterol-lowering diet is in its infancy. Careful studies controlling for the clinical influences of responsiveness are needed so that true biological determinants of response can be uncovered.

Apoproteins↗

Individual responsiveness to a cholesterol-lowering diet in postmenopausal women with moderate hypercholesterolemia.

BACKGROUND: The efficacy of the step 1 diet in outpatient women with hypercholesterolemia has been debated. METHODS: Forty-one normotriglyceridemic women whose low-density lipoprotein (LDL) cholesterol levels were 3.62 to 5.17 mmol/L (140 to 200 mg/dL) participated in a two-period outpatient diet counseling study that used a 1-month high-fat, high-saturated fatty acid period (Hi-Sat diet) and a 4-month low-fat, low-saturated fatty acid period (step 1 diet). All women were postmenopausal and were not taking hormone replacement therapy. Levels of lipids, lipoproteins, and plasma triglyceride fatty acids were measured five times during the last 2 weeks of each dietary period. Dietary intake was assessed by 7-day food records. RESULTS: The mean reduction in total cholesterol level achieved by the step 1 diet was 0.36 mmol/L (14 mg/dL). The reduction in total cholesterol level was seen in both LDL cholesterol levels (0.28 mmol/L [11 mg/dL]; P < .005) and high-density lipoprotein cholesterol levels (0.08 mmol/L [3 mg/dL]; P = .08). Although individual LDL responsiveness to diet was normally distributed, there was marked variation in response, which could be explained only partially by compliance (change in saturated fat intake, 10%), change in body weight (3%), and an interaction between the palmitic acid content of the plasma and body weight (3%). CONCLUSIONS: A step 1 diet lowers total and LDL cholesterol levels in postmenopausal women. A nonsignificant reduction in high-density lipoprotein cholesterol levels was also observed. Since some women achieved LDL cholesterol levels low enough to obviate the need for drug therapy as primary prevention of coronary heart disease, dietary therapy should remain the first step in the management of hypercholesterolemia in postmenopausal women.

Aged↗

Excess body weight. An under-recognized contributor to dyslipidemia in white American women.

BACKGROUND: Whether the association between excess body weight and dyslipidemia is consistent across different age ranges in women has yet to be determined. METHODS: The relationship between body weight adjusted for height as calculated by body mass index (BMI; kilograms per square meter) and serum lipid and lipoprotein levels in white women was examined using cross-sectional data from the Second National Health and Nutrition Examination Survey. Mean lipid levels were determined for six different categories of BMI: (1) 21.0 or less; (2) 21.1 to 23.0; (3) 23.1 to 25.0; (4) 25.1 to 27.0; (5) 27.1 to 30.0; and (6) more than 30.0, and three age groups: premenopausal women, 20 through 44 years; perimenopausal women, 45 through 59 years; and postmenopausal women, 60 through 74 years. RESULTS: Compared with BMI category 2, a BMI in category 5 for premenopausal women was associated with 0.46 mmol/L (18 mg/dL) higher total cholesterol levels, 0.68 mmol/L (26 mg/dL) higher non-high-density lipoprotein (HDL) cholesterol levels, and 0.44 mmol/L (17 mg/dL) higher low-density lipoprotein (LDL) cholesterol levels. For perimenopausal women and postmenopausal women the same change in BMI was associated with much smaller differences in total cholesterol of 0.16 and 0.16 mmol/L (6 and 5 mg/dL), non-HDL of 0.24 and 0.20 mmol/L (9 and 8 mg/dL), and LDL levels of 0.13 and 0.03 mmol/L (5 and 1 mg/dL). More impressively, rising BMI was associated with consistently higher triglyceride levels of 0.54 to 0.40 mmol/L (48 to 35 mg/dL) and consistently lower HDL levels of 0.23 to 0.13 mmol/L (9 to 5 mg/dL), in all three age groups. CONCLUSION: For young women, excess body weight was associated with higher total, non-HDL and LDL-cholesterol levels, higher triglyceride levels, and lower HDL-cholesterol levels. In older women, although similar differences in triglyceride levels and HDL-cholesterol levels were observed, excess body weight was associated with smaller differences in total, non-HDL, and LDL cholesterol. More striking than the weight-associated differences in total, non-HDL, and LDL-cholesterol levels were the differences in these lipid parameters observed with age alone. Specifically, age category differences were twofold to eightfold greater than differences observed between categories of BMI within a given age. Nevertheless, because the lower HDL cholesterol concentrations associated with excess body weight were age independent, total cholesterol-HDL cholesterol ratios were highest in obese postmenopausal women. Although age and hormonal status are important affecters of lipoprotein risk factors, body weight also worsens the degree of dyslipidemia in white women.

Adult↗

Individual responses to a cholesterol-lowering diet in 50 men with moderate hypercholesterolemia.

BACKGROUND: Dietary modification is the recommended first step in the treatment of hypercholesterolemia. However, the efficacy of the National Cholesterol Education Program Step 1 Diet in outpatients with hypercholesterolemia has been debated. METHODS: Fifty normotriglyceridemic men whose ad libitum low-density lipoprotein (LDL) cholesterol levels were 4.14 to 5.69 mmol/L (160 to 220 mg/dL) participated in a two-period outpatient diet counseling study that used a 1-month high-fat, high-saturated fatty acid period (Hi-Sat) and a 4-month low-fat, low-saturated fatty acid period (Step 1 Diet). Lipid, lipoprotein levels, and plasma triglyceride fatty acids were measured five times during the last 2 weeks of each dietary period and averaged for each patient. Dietary intake was assessed by 7-day food records. During the Hi-Sat period, an LDL turnover study was done to determine the fractional catabolic rate of LDL. RESULTS: The mean reduction in total and LDL cholesterol levels achieved by diet was 0.54 mmol/L (21 mg/dL) and 0.39 mmol/L (15 mg/dL), respectively. These responses equaled those predicted from metabolic ward investigations. While dietary responsiveness was normally distributed, there was marked individual variation in response. The mean (+/- SD) for quartiles of LDL responsiveness were +0.41 +/- 0.21 mmol/L (+16 +/- 8 mg/dL), -0.16 +/- 0.13 mmol/L (-6 +/- 5 mg/dL), -0.57 +/- 0.16 mmol/L (-22 +/- 6 mg/dL), and -1.16 +/- 0.26 mmol/L (-45 +/- 10 mg/dL). These differences in response were partially explained by dietary adherence, baseline fractional catabolic rates of LDL, and the change in plasma triglyceride palmitate level. CONCLUSIONS: The Step 1 Diet is effective in lowering LDL cholesterol levels for many hypercholesterolemic men, and with appropriate counseling, outpatients can achieve results predicted by inpatient metabolic diet studies. Nonetheless, the responsiveness for individuals is highly variable, and this variability is influenced by both compliance and biologic factors. Since many men achieved LDL cholesterol levels low enough to remove the need for drug therapy in primary prevention for coronary heart disease, dietary therapy should remain the initial approach to the treatment of hypercholesterolemia.

Adult↗

Diet and lifestyle modification and its relationship to atherosclerosis.

Much of the CHD protective effects of diet are mediated through the effects of diet on risk factor levels. The best studied are the effects of diet on lipoprotein levels and blood pressure. With these effects in mind, specific dietary recommendations have been made to reduce CHD rates among healthy Americans. Dietary modification will reduce risk factor levels in the majority of people and will have measurable impact on CHD rates in the nation (Table 9). In the treatment of patients, it is important to distinguish which lipoprotein and blood pressure abnormalities are amenable to diet and which ones require drug therapy. This distinction can be made by understanding the quantitative relationship between dietary intake and risk factor levels that has been presented here and by assessing the current dietary intake of the individual. There must be a significant change in dietary composition to produce a significant change in risk factor level. This point, although it appears obvious when stated, is a common source of confusion concerning the efficacy of diet. For individuals, most nonresponse to dietary change reflects the lack of a dietary change. Poor adherence, in turn, may be the direct result of inadequate diet counseling. Counseling with a registered dietitian may be useful not only in educating the high-risk patient concerning the nutrient content of food, but also in establishing the current dietary intake of the patient. Compliance is not the only cause of nonresponse. For some patients who are already following a CHD prevention diet, additional risk factor reductions may not be evident when minor dietary constituents are altered. Because the majority of the diet effect has already been achieved, this "nonresponse" should not be surprising. The benefit of a change in a minor dietary constituent may not be detectable above the random day-to-day variation in risk factor levels. Lastly, although true nonresponders to diet have been observed, at least for blood cholesterol levels, the prevalence of nonresponse or minimal response is less than 10% of the population. Although the small changes in risk factor levels achieved by diet cannot compare with the greater changes achieved by drug therapy, dietary therapy will always have an important place in altering the health of the United States and its people. For some individuals, dietary and lifestyle modification may be all that is needed for CHD prevention; for others, dietary and lifestyle modifications provide a foundation on which drug therapy can be added for maximum CHD risk reduction.

Arteriosclerosis↗

Effects of cocoa butter on serum lipids in humans: historical highlights.

It has been known for some time that cocoa butter, although rich in saturated fatty acids, does not raise total serum cholesterol concentrations as much as expected from its total saturated fatty acid content. Whether the effect of cocoa butter feeding on low-density-lipoprotein- (LDL)-cholesterol concentrations was also less than predicted by its total saturated fatty acid content needed to be tested. In a recent experiment cocoa butter did not raise LDL cholesterol as much as predicted by its total saturated fatty acid content. However, because of its significant palmitic acid content, cocoa butter did raise LDL-cholesterol concentrations more than do most liquid vegetable oils.

Cholesterol↗

Role of beef and beef tallow, an enriched source of stearic acid, in a cholesterol-lowering diet.

The effects of stearic acid on metabolism must be evaluated for stearic acid as an isolated dietary constituent and for stearic acid as a component of a natural fat. Beef products are the most common source of dietary stearic acid in the United States. Two components of beef products, beef protein and beef fat, can potentially impart cholesterol-raising properties. Protein has minimal effects on cholesterol concentrations in humans, but studies suggest that beef fat raises serum cholesterol concentrations. Because beef fat is 19% stearic acid, the cholesterol-raising potential of beef is not as great as predicted by its total saturated fatty acid content. However, beef tallow is hypercholesterolemic compared with fats containing less cholesterol-raising saturated fatty acid. Therefore, curtailment of beef tallow in a cholesterol-lowering diet seems appropriate. Data suggest that lean beef is no more hypercholesterolemic than chicken or fish and, therefore, lean beef need not be eliminated from cholesterol-lowering diets.

Animals↗

Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men.

BACKGROUND: The influence of body weight on serum lipids is often overlooked in clinical practice. METHODS: The association between body weight adjusted for height as calculated by body-mass index (BMI) and serum lipid and lipoprotein levels in white men was examined using the second National Health and Nutrition Examination Survey (NHANES II). Lipid results were categorized into six different levels of BMI: (1) 21.0 kg/m2 or lower, (2) 21.1 to 23.0 kg/m2, (3) 23.1 to 25.0 kg/m2, (4) 25.1 to 27.0 kg/m2, (5) 27.1 to 30.0 kg/m2, and (6) greater than 30.0 kg/m2, and three age groups: (1) young men (20 through 44 years), (2) middle-aged men (45 through 59 years), and (3) older men (60 through 74 years). RESULTS: Using linear trend analysis, changes in BMI from categories 2 to 5 in young men were associated with a total cholesterol level 0.59 mmol/L (23 mg/dL) higher (P < .01), a non-high-density lipoprotein (non-HDL) cholesterol level 0.70 mmol/L (27 mg/dL) higher (P < .01), and a low-density lipoprotein (LDL) cholesterol level 0.59 mmol/L (23 mg/dL) higher (P = .03). For middle-aged men and older men, the same change in BMI was associated with smaller but still significant differences in total cholesterol levels (higher by 0.31 mmol/L [12 mg/dL] [P < .01] and 0.28 mmol/L [11 mg/dL] [P < .01], respectively) and non-HDL cholesterol levels (higher by 0.37 mmol/L [14 mg/dL] [P < .01] and 0.25 mmol/L [10 mg/dL] [P < .01], respectively), whereas the LDL cholesterol levels were unchanged. Although advancing age may blunt the BMI-associated differences in total and LDL cholesterol levels, the BMI-associated differences in triglyceride levels (higher by 0.70 to 1.33 mmol/L [62 to 118 mg/dL] [P < .001]) and HDL cholesterol levels (lower by 0.18 to 0.39 mmol/L [7 to 15 mg/dL] [P < .001]) were of similar magnitude in all age groups. CONCLUSION: Excess body weight is associated with deleterious changes in the lipoprotein profile. Higher BMI was associated at all ages with higher plasma triglyceride level, lower HDL cholesterol level, and higher total and non-HDL cholesterol levels. In young men, the higher total cholesterol level was reflected mainly in the LDL cholesterol level; in middle-aged and older men, in the non-HDL fraction. Programs to reduce coronary heart disease by improving lipid levels should include more emphasis on achieving and maintaining ideal body weight.

Adult↗

Response to a cholesterol-lowering diet: efficacy is greater in hypercholesterolemic subjects even after adjustment for regression to the mean.

PURPOSE: To define how much regression to the mean confounds apparent responsiveness in subgroup analyses, and to test, using techniques that remove regression to the mean, whether hypercholesterolemic subjects are more likely to respond to diet. PATIENTS AND METHODS: Data collected on 812 men and women participating in the Minnesota Coronary Survey Dietary Trial who had at least 2 total cholesterol measurements on a high-saturated-fat diet and 1 cholesterol measurement on a low-saturated-fat diet were analyzed for the effects of initial serum cholesterol and regression toward the mean on measurement of diet responsiveness. RESULTS: If regression towards the mean is not taken into account, dietary responsiveness in patients with mean cholesterol levels of 280 mg/dL was -25%, whereas dietary responsiveness in subjects with mean serum cholesterol levels of 156 mg/dL was -5%. After regression toward the mean was taken into account, subjects with high initial serum cholesterol levels had an 18% reduction in serum cholesterol levels whereas subjects with lower levels had an 11% reduction. Even after regression toward the mean is accounted for, subjects with high serum cholesterol levels were significantly more diet-responsive (p < 0.005). CONCLUSION: The efficacy of a cholesterol-lowering diet for individuals can be overestimated or underestimated if only single measurements are used to determine response. Subjects with hypercholesterolemia, even after adjustment for regression towards the mean, are more diet-responsive than subjects with lower cholesterol levels. Dietary therapy should remain the first step in the treatment of hypercholesterolemia, and should also be effective in reducing cholesterol levels in the population at large.

Adult↗

Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men.

The effect of dietary calcium on fecal fatty acid excretion and serum lipids was tested in a randomized, single-blind metabolic study in 13 healthy men with moderate hypercholesterolemia. A low calcium base diet containing 34% of energy from fat, 13% from saturated fatty acids, 240 mg cholesterol/d and 410 mg Ca/d was compared with a fortified version in which calcium citrate malate was added to orange juice, (550 mg) muffins (750 mg), and two tablets (500 mg) for a total calcium intake of 2200 mg/d. Fecal collections (72 h, d 8, 9, 10) and blood from fasting subjects for lipids and lipoproteins (d 9, 10, 11) were obtained. The percentage of dietary saturated fat excreted per day increased from 6 to 13% with calcium fortification. There was no change in fecal bile acid excretion. The high Ca diet significantly reduced total cholesterol 6% (5.99 to 5.66 mmol/L), LDL cholesterol 11% (4.13 to 3.67 mmol/L), and apolipoprotein B concentrations 7% when compared with the low Ca diet (P < 0.05). There was no change in HDL cholesterol or apolipoprotein A1 concentrations. Urinary calcium excretion increased from 146 to 230 mg/d when the high Ca diet was consumed. Calcium fortification was effective in lowering total and LDL cholesterol concentrations and may be an effective adjunct to cholesterol-lowering diet therapy.

Adult↗

Comparison of effects of lauric acid and palmitic acid on plasma lipids and lipoproteins.

The effects of lauric acid (C12:0) on plasma lipids and lipoproteins were compared with the effects of palmitic acid (C16:0) and oleic acid (C18:1) in a metabolic-diet study of 14 men by using liquid-formula diets fed for 3 wk each in random order. Lauric acid was supplied in a synthetic high-lauric oil, palmitic acid was provided by palm oil and oleic acid in oleic-rich sunflower seed oil. The high-lauric oil resulted in higher concentrations of plasma total cholesterol (4.94 +/- 0.75 mmol/L [mean +/- SE]) and LDL cholesterol (3.70 +/- 0.57 mmol/L) when compared with high-oleic sunflower oil (4.44 +/- 0.54 and 3.31 +/- 0.44 mmol/L, respectively), but did not raise total and LDL cholesterol concentrations as much as did palm oil (5.17 +/- 0.65 and 3.93 +/- 0.51 mmol/L, respectively). No differences were noted in plasma triglycerides or HDL cholesterol. Lauric acid raises total and LDL cholesterol concentrations compared with oleic acid, but is not as potent for increasing cholesterol concentrations as is palmitic acid.

Adult↗

Effects of fats high in stearic acid on lipid and lipoprotein concentrations in men.

The effects of beef tallow and cocoa butter, two fats with a high stearic acid content (C18:0), on serum lipid and lipoprotein concentrations were compared with the effects of butter fat and olive oil in 10 middle-aged men. Liquid-formula diets containing 40% of the calories from the test fat were fed in random order for 3 wk each, with lipoprotein concentrations measured on the last five days. Butter fat raised low-density lipoprotein (LDL) concentrations the most (4.23 +/- .15 mmol/L; mean +/- SE). Beef-tallow feeding resulted in significantly lower concentrations of LDL (4.03 +/- 0.18 mmol/L); cocoa butter resulted in even lower concentrations (3.82 +/- .15 mmol/L). The lowest concentration of LDL was observed with olive oil (3.62 +/- 0.18 mmol/L). Fecal excretion of fatty acids, after adjustment for fecal flow, indicated that oleic acid (C18:1) was 99% absorbed, palmitic acid (C16:0) was 96-97% absorbed, and stearic acid was 90-94% absorbed for the three fats containing significant amounts of stearic acid.

Absorption↗

Metabolic basis of primary hypercholesterolemia.

BACKGROUND: Hypercholesterolemia is a well-established risk factor for coronary heart disease. However, the mechanisms underlying hypercholesterolemia, elevated low density lipoprotein (LDL) in particular, are not well understood. To determine these mechanisms, we studied LDL kinetics in a group of men with primary hypercholesterolemia. METHODS AND RESULTS: LDL kinetics in 134 middle-aged men with high-risk levels of LDL cholesterol (more than 160 mg/dl) were compared with kinetics in 16 men with borderline high-risk levels of LDL cholesterol (120-159 mg/dl) and 14 men with heterozygous familial hypercholesterolemia (FH). Patients with primary hypercholesterolemia (non-FH) were further divided into moderate hypercholesterolemia (LDL cholesterol, 160-210 mg/dl; n = 108) and severe hypercholesterolemia groups (LDL cholesterol, more than 210 mg/dl; n = 26). Four factors contributed to increasing LDL cholesterol concentrations above the borderline range to moderately elevated levels: 37 patients had no increase in LDL apolipoprotein (apo) B levels but had abnormally high LDL cholesterol-to-apo B ratios; 14 patients had very low fractional catabolic rates (FCRs) for LDL, similar to FH patients; 35 patients had FCRs for LDL in the borderline range but high production rates for LDL; and 22 patients had a high flux of LDL (high production rates and high FCRs). In general, patients with severe hypercholesterolemia resembled those with moderate LDL elevations, except that their LDL particles were enriched with cholesterol. CONCLUSIONS: Data from the present study reveal that there are several distinct patterns of LDL metabolism responsible for primary hypercholesterolemia. These patterns can serve as the basis for further investigation to determine the molecular defects responsible for each pattern.

Adult↗

Influence of lifetime cross-country skiing on plasma lipids and lipoproteins.

Low concentrations of total and LDL cholesterol are associated with minimal risk of atherosclerosis. Aerobic exercise has been similarly associated with a low risk of heart disease. The literature is inconclusive as to whether there is an association between total and LDL cholesterol and exercise. Further, previous work has, almost exclusively, examined male runners. Therefore, we examined 176 male and female cross-country skiers, participating in the National Master's Championships, for body composition, dietary habits, exercise habits, and serum lipid levels. Our results show markedly low concentrations of serum LDL cholesterol and total cholesterol, as well as the expected high concentrations of HDL cholesterol and low concentrations of triglycerides, in these lean skiers. Their diets contained 30% fat, and they exercised 9 h weekly. Although it is difficult to separate the effects of diet, leanness, and exercise on the lipid profile, it is apparent that the lifestyle led by these people is associated with a lipid profile that confers an extremely low risk of atherosclerotic disease.

Adult↗

Hypercholesterolemia in elderly persons: resolving the treatment dilemma.

Of all age groups, men and women over 60 years of age have the highest prevalence of elevated serum cholesterol levels. Now that detection and treatment of high serum cholesterol levels are increasing, we need a rational approach to managing elevated cholesterol levels in elderly patients. Recent data indicate that high total cholesterol and low-density lipoprotein levels predict risk for coronary heart disease in patients over 60 years of age. However, selecting appropriate candidates for cholesterol-lowering therapy requires clinical judgment of the relative risks and benefits of each therapy and consideration of each patient's overall health status as well as of competing risks. Active medical management of high cholesterol levels, therefore, should be restricted to a limited fraction of elderly patients who are most likely to benefit from long-term therapy. The first line of treatment is diet modification; however, drug therapy for appropriate patients is not contraindicated because of age alone.

Aged↗

Dietary influences on serum lipids and lipoproteins.

Substantial data are available to indicate that the diet influences serum levels of cholesterol and lipoproteins. These data are derived from studies in laboratory animals, from epidemiologic studies, and from human investigations. Most research has focused on effects of diet on serum total cholesterol concentrations. In recent years, however, attention has shifted to individual lipoproteins, i.e., low density lipoproteins (LDL), high density lipoproteins (HDL), and very low density lipoproteins (VLDL). Three nutritional factors have been identified that raise serum LDL levels; these are saturated fatty acids, cholesterol itself, and excess caloric intake leading to obesity. The major cholesterol-raising saturated fatty acid in the diet is palmitic acid. Several nutrients can be substituted for saturated fatty acids to produce a reduction in LDL-cholesterol levels. These are polyunsaturated fatty acids, monounsaturated fatty acids, carbohydrates, and even one saturated fatty acid, stearic acid. The latter appears to be converted rapidly into a monounsaturated fatty acid in the body. Any of these nutrients can be used for replacement of cholesterol-raising saturated fatty acids in the diet. However, their relative effects on other metabolic processes remain to be determined fully. At present it appears that carbohydrates and monounsaturated fatty acids represent the preferred replacements for saturated fatty acids, although modest increases in polyunsaturated fatty acids and stearic acid, at the expense of cholesterol-raising saturates, probably are safe and may provide for greater variety in the diet.

Animals↗